PharmD, PhD, MBA

► 20 years of experience in the biotechnology industry in  business development, Management, finance and  intellectual property strategy;
► CEO of TechnoPhage and Member of the Board of  Directors of Vector B2B;
► Education in pharmaceutical sciences, followed by a  PhD in pharmacy and an executive MBA.

PhD

► + 20 years experience in the pharmaceutical industry  where he was Research portfolio manager in the  pharmaceutical strategy unit of Hoffmann-La Roche,  Managing Director at Biopolo Ticino, Business  Development Director at Actelion and NovImmune and  Chief Business Officer at Axoltis Pharma;
► Founder and Vice-President of the Swiss Biotech  Association.

PharmD

► Member of the Board of Directors of TechnoPhage  and Vector B2B;
► Co-founder of Lusomedicamenta (Recipharm);
► Senior manager in multinational pharmaceutical  companies;
► PharmD, Faculty of Pharmacy, University of Lisbon

► + 25 years of experience in early-stage business  development, Management, finance, private equity  and M&A;
► Founder and member of the Board of Directors of  IBV – Innovations Bioventures;
► Member of the Board of Directors of Eaglestone  Capital Partners, SCR;
► Chairman of the General Meeting of the Medinfar  Group.

► Professor of Biochemistry at the Faculty of Medicine of the University of Lisbon;
► Head Researcher at the Institute of Molecular Medicine, focusing on the discovery and development of drugs directed to the central nervous system;
► Co-author of over 180 scientific papers published in renowned scientific journals  and 4 patents in partnership with biotechnology companies.